Pancreatic Cancer Research

ResearcherNorthern Jiangsu People's HospitalActive in the last 2 years

Dong Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0009-6687-3617; OpenAlex author ID A5008952484. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 5 papers · 2023: 1 paper · 2024: 2 papers

Papers 12

  1. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review. Last author DOI 10.1016/j.ijbiomac.2024.130149↗
  2. Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy. Last author DOI 10.1111/imm.13765↗
  3. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. Last author DOI 10.1016/j.canlet.2022.216031↗
  4. The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier. First author DOI 10.1016/j.bbcan.2022.188733↗
  5. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. Last author DOI 10.1111/imm.13496↗
  6. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. Last author DOI 10.1186/s12964-021-00806-y↗
  7. Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. Last author DOI 10.1186/s12964-021-00808-w↗
  8. Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14225475↗
  9. CD248(TEM1/CD164L1/Endosialin): A new molecular target for anti-angiogenic therapy in Pancreatic ductal adenocarcinoma Last author DOI 10.21203/rs.3.rs-217476/v1↗
  10. Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. Last author DOI 10.3389/fcell.2021.783617↗
  11. Galectin-1 expression in activated pancreatic satellite cells promotes fibrosis in chronic pancreatitis/pancreatic cancer via the TGF-β1/Smad pathway. Co-author DOI 10.3892/or.2018.6202↗
  12. Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer. Last author DOI 10.1016/j.mehy.2013.03.027↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daorong Wang · 10 shared papers, 2013–2024 · strength 1.63
  2. Zhilin Zhang · 4 shared papers, 2021–2023 · strength 0.91
  3. Huan Zhang · 5 shared papers, 2021–2022 · strength 0.85
  4. Wenjie Zhang · 4 shared papers, 2021–2024 · strength 0.76
  5. Gengyu Sha · 3 shared papers, 2022–2024 · strength 0.68
  6. Zhengting Jiang · 2 shared papers, 2023–2024 · strength 0.53
  7. Zhengting Jiang · 2 shared papers, 2022–2024 · strength 0.46
  8. Qihang Wu · 1 shared paper, 2024 · strength 0.31
  9. Lin Shi · 1 shared paper, 2022 · strength 0.20
  10. Ying Tian · 1 shared paper, 2018 · strength 0.07
  11. Zhongxu Yuan · 1 shared paper, 2018 · strength 0.07
  12. Hui Chen · 1 shared paper, 2013 · strength 0.04
  13. Chuanli Ren · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.